| CAA | cancer-associated adipocyte |
| TME | tumor microenvironment |
| COX-2 | cyclooxygenase-2 |
| NSAID | nonsteroidal anti-inflammatory drug |
| FA | fatty acid |
| BMI | body mass index |
| PG | prostaglandin |
| PPAR | peroxisome proliferator-activated receptor |
| C/EBP | CCAAT enhancer binding protein |
| IL | interleukin |
| TNFα | tumor necrosis factor α |
| FFA | free fatty acid |
| FAO | fatty acid oxidation |
| TG | triacylglycerol |
| MMP | matrix metalloproteinase |
| CCL2 | chemokine ligand 2 |
| VEGF | vascular endothelial growth factor |
| ECM | extracellular matrix |
| EMT | epithelial-mesenchymal transition |
| IGF | insulin-like growth factor |
| IGFBP | IGF binding protein |
| AP1 | activator protein-1 |
| MSC | mesenchymal stem cell |
| CiDA | compression-induced dedifferentiated adipocytes |
| LPS | liposarcoma |
| AP2 | adipocyte protein 2 |
| TGFβ | transforming growth factor β |
| MCP1 | monocyte chemoattractant protein-1 |
| PPRE | PPAR response element |
| PLIN1 | perilipin1 |
| HSL | hormone sensitive lipase |
| CCR2 | C-C chemokine receptor type 2 |
| cAMP | cyclic AMP |
| PKA | protein kinase A |
| ATGL | adipose triglyceride lipase |
| JAK | Janus kinase |
| STAT | signal transducer and activator of transcription |
| EV | extracellular vesicle |
| FAP | familial adenomatous polyposis |
| OR | odds ratio |
| CI | confidence interval |
| HR | hazard ratio |